These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4663715)

  • 21. Inhibition, by drugs, of galactosamine induced hepatitis in the rat.
    Pickering RW; Lynn James GW; Parker FL
    Arzneimittelforschung; 1975 Oct; 25(10):1591-2. PubMed ID: 1243044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of LDL-apoproteins in D-galactosamine-induced hepatitis in rats.
    Nadkarni GD; Pestonjamasp KN
    Indian J Biochem Biophys; 1984 Feb; 21(1):57-8. PubMed ID: 6490058
    [No Abstract]   [Full Text] [Related]  

  • 23. [Function of lysosomal enzymes in galactosamine hepatitis].
    Heissmeyer H; Stein U
    Verh Dtsch Ges Inn Med; 1972; 78():1377-80. PubMed ID: 4665551
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antihepatotoxic activity of arginine thiazolidinecarboxylate in hepatitis induced by galactosamine in the rat].
    Carminati R; Falchi M; Nebuloni R; Guadagni L; Lodi R
    Farmaco Prat; 1979 Apr; 34(4):163-7. PubMed ID: 456554
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison between the morphologic changes in the livers of hamsters and rats after galactosamine treatment and their correlation with altered serum transaminase levels.
    Pickering RW
    Arzneimittelforschung; 1977; 27(9):1684-7. PubMed ID: 579138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Primary and secondary liver response to D-galactosamine administration in galactosamine hepatitis].
    Reutter W; Bauer C; Bachman W; Lesch R
    Verh Dtsch Ges Inn Med; 1973; 79():927-30. PubMed ID: 4790045
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of the liver protecting compound ES 914 on D-galactosamine induced experimental hepatitis in the rat].
    Wegmann A; Chariatte N; Renker H; Dittrich A
    Arzneimittelforschung; 1979; 29(1):68-70. PubMed ID: 582121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental galactosamine-induced hepatitis. Effect of anticoagulant and antifibrinolytic agents on microclot formation.
    Müller-Berghaus G; Reuter C; Bleyl U
    Am J Pathol; 1976 Feb; 82(2):393-406. PubMed ID: 1251892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of periarterial hepatic neurectomy on the hepatic blood flow and oxygen metabolism in the course of experimental hepatitis].
    Bielicki F; Oleszkiewicz L; Szydlowski Z
    Rev Int Hepatol; 1965; 15(4):613-23. PubMed ID: 5832090
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of uridine entrapped in liposomes in galactosamine-induced hepatitis.
    Mathias C; Dorai DT; Bachhawat BK
    Indian J Biochem Biophys; 1977 Jun; 14(2):142-6. PubMed ID: 590978
    [No Abstract]   [Full Text] [Related]  

  • 31. The protective effect of a novel compound RU 18492, on galactosamine-induced hepatotoxicity in the rat.
    James GW; Pickering RW
    Arzneimittelforschung; 1976; 26(12):2197-9. PubMed ID: 1037274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of prednisolone on the development of the galactosamine hepatitis of young and old rats (author's transl)].
    Platt D; Leinweber B; Förster L; Förster K
    Aktuelle Gerontol; 1976 Jun; 6(6):267-78. PubMed ID: 14531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The significance of age for morphological and biochemical changes in galactosamine hepatitis].
    Platt D
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():249-51. PubMed ID: 1029185
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatic circulation in hepatitis A.
    Lundbergh P
    Acta Med Scand Suppl; 1974; 562():1-56. PubMed ID: 4618419
    [No Abstract]   [Full Text] [Related]  

  • 35. The electromagnetic measurement of liver blood flow and cardiac output in conscious dogs during feeding and exercise.
    Hopkinson BR; Schenk WG
    Surgery; 1968 Jun; 63(6):970-5. PubMed ID: 5648722
    [No Abstract]   [Full Text] [Related]  

  • 36. [Incorporation of 14-C-Glycine during galactosamine hepatitis of young and old rats (author's transl)a*].
    Platt D; Förster L; Förster K
    Aktuelle Gerontol; 1976 Jul; 6(7):319-27. PubMed ID: 14537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aggravating and protecting effects of triton and corticosteroids in galactosamine-induced hepatitis.
    Grases PJ; Lesch R; Stein U; Heissmeyer H; Reutter W
    G E N; 1972; 27(1):77-89. PubMed ID: 4632028
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effect of D-penicillamine on the galactosamine hepatitis model in the rat].
    Habersang S; Kozlik V; Leuschner F; von Schlichtegroll A
    Arzneimittelforschung; 1973 Jan; 23(1):56-7. PubMed ID: 4740696
    [No Abstract]   [Full Text] [Related]  

  • 39. Circulatory events accompanying liver regeneration following partial hepatectomy.
    Menyhárt J; Simon L
    Acta Physiol Acad Sci Hung; 1966; 30(2):169-74. PubMed ID: 5989865
    [No Abstract]   [Full Text] [Related]  

  • 40. [The action of silymarin on Galactosamine-induced hepatitis in the rat (author's transl)].
    Barbarino F; Suciu A; Cotutiu C; Ban A
    Wien Klin Wochenschr; 1977 Feb; 89(3):90-5. PubMed ID: 189515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.